BenevolentAI uses AI to accelerate biopharma drug discovery and provide life science intelligence.
What is BenevolentAI?
Renshan AI (Euronext Amsterdam: BAI) is a company that utilizes advanced artificial intelligence to accelerate the discovery of biopharmaceutical drugs. Its next-generation platform is designed to assist in making complex decisions throughout the research and development process, thereby enhancing the capabilities of life sciences. The company develops its technologies within the context of scientific services, bringing together scientific and technical teams to push the boundaries of AI and machine learning. By leveraging knowledge graphs and proprietary ontologies, Renshan AI enables scientists and executives to utilize cutting-edge artificial intelligence technologies in a confident and precise manner.
How to use BenevolentAI?
This website provides information about the Renshan AI platform and its applications in drug discovery. Users can learn more about the company’s philosophy, contact them for additional details, and access various resources such as regulatory documents, terms of service, privacy policies, cookie notices, accessibility information, and site maps.
The core functions of BenevolentAI
AI-based drug discovery platform
Knowledge graphs and specialized ontologies
Intelligence in Life Sciences